Defective expression of T-cell CD40 ligand causes X-linked immunodeficiency with hyper-IgM


XCHROMOSOME-LINKED immunodeficiency with hyper-IgM (HIGM1, MIM number 308230) is a rare disorder characterized by recurrent bacterial infections, very low or absent IgG, IgA and IgE, and normal to increased IgM and IgD serum levels1–3. HIGM1 has been suggested to result from ineffective T-cell help for B cells4. We and others5–8 have identified a novel, TNF-related activation protein (TRAP) that is exclusively expressed on the surface of stimulated T cells6,8. TRAP, a type II transmembrane protein of Mr 33,000, is the physiological ligand for CD40 (refs 5–8). Crosslinking of CD40 on B cells induces, in the presence of lymphokines, immunoglobulin class switching from IgM to IgG, IgA or IgE5,9–11. Mapping of the TRAP gene to the X-chromosomal location q26.3–q27.1 (ref. 6) suggested a causal relationship to HIGM1, which had previously been assigned to Xq26 (refs 12–14). Here we present evidence that point mutations in the TRAP gene give rise to nonfunctional or defective expression of TRAP on the surface of T cells in patients with HIGM1. The resultant failure of TRAP to interact with CD40 on functionally intact B cells is responsible for the observed immunoglobulin isotype defect in HIGM1.

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.


All prices are NET prices.


  1. 1

    Rosen, F. S., Kevy, S. V., Merler, E., Janeway, C. A. & Gitlin, D. Pediatrics 28, 182–195 (1961).

    CAS  PubMed  Google Scholar 

  2. 2

    Burtin, P. Rev. Fr. Etud. clin. Biol. 6, 286–289 (1961).

    CAS  PubMed  Google Scholar 

  3. 3

    Notarangelo, L. D., Duse, M. & Ugazio, A. G. Immunodef. Rev 3, 101–121 (1992).

    CAS  PubMed  Google Scholar 

  4. 4

    Mayer, L. et al. New Engl. J. Med. 314, 409–413 (1986).

    CAS  Article  Google Scholar 

  5. 5

    Armitage, R. J. et al. Nature 357, 80–82 (1992).

    ADS  CAS  Article  Google Scholar 

  6. 6

    Graf, D., Korthäuer, U., Mages, H. W., Senger, G. & Kroczek, R. A. Eur. J. Immun. 22, 3191–3194 (1992).

    CAS  Article  Google Scholar 

  7. 7

    Hollenbaugh, D. et al. EMBO J. 11, 4313–4321 (1992).

    CAS  Article  Google Scholar 

  8. 8

    Spriggs, M. K. et al. J. exp. Med. 176, 1543–1550 (1992).

    CAS  Article  Google Scholar 

  9. 9

    Jabara, H. H., Fu, S. M., Geha, R. S. & Vercelli, D. J. exp. Med. 172, 1861–1864 (1990).

    CAS  Article  Google Scholar 

  10. 10

    Rousset, F., Garcia, E. & Banchereau, J. J. exp. Med. 173, 705–710 (1991).

    CAS  Article  Google Scholar 

  11. 11

    Defrance, T. et al. J. exp. Med. 175, 671–682 (1992).

    CAS  Article  Google Scholar 

  12. 12

    Mensink, E. J. B. M. et al. Hum. Genet. 76, 96–99 (1987).

    CAS  Article  Google Scholar 

  13. 13

    Padayachee, M. et al. Genomlcs 14, 551–553 (1992).

    CAS  Article  Google Scholar 

  14. 14

    Padayachee, M. et al. J. med. Genet. (in the press).

  15. 15

    Bonifacino, J. S., Cosson, P., Shah, N. & Klausner, R. D. EMBO J. 10, 2783–2793 (1991).

    CAS  Article  Google Scholar 

  16. 16

    Liu, Y. J. et al. Nature 342, 929–931 (1989).

    ADS  CAS  Article  Google Scholar 

  17. 17

    Banchereau, J. & Rousset, F. Nature 353, 678–679 (1991).

    ADS  CAS  Article  Google Scholar 

  18. 18

    Hermann, P. et al. Eur. J. Immun. (in the press).

Download references

Author information



Rights and permissions

Reprints and Permissions

About this article

Cite this article

Korthäuer, U., Graf, D., Mages, H. et al. Defective expression of T-cell CD40 ligand causes X-linked immunodeficiency with hyper-IgM. Nature 361, 539–541 (1993).

Download citation

Further reading


By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.


Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing